What is a clinical trial?
Clinical trials are structured research studies designed to answer specific questions about an intervention. Researchers define who can participate, what outcomes will be measured, how long participants will be followed and how results will be analysed.
Phases of development
Early studies generally focus on safety, tolerability, pharmacology and dose selection. Later-stage studies evaluate whether an intervention produces meaningful outcomes in larger groups and continue to monitor safety. Phase 3 trials are typically large, controlled studies intended to provide evidence for regulatory decisions.
What are endpoints?
An endpoint is a predefined outcome used to assess a study question. Endpoints can include changes in body weight, blood markers, symptoms, quality-of-life measures or clinical events, depending on the trial.
How to read results
Look beyond a single headline number. Check the population studied, duration, comparator, dose, number of participants, primary endpoint, uncertainty around estimates and adverse-event reporting.
Retatrutide research
Retatrutide is being studied in multiple Phase 3 programmes. Current studies include obesity and related cardiometabolic conditions. Study status and findings can change as trials are completed and results are published.
Current retatrutide trial landscape
Lilly is conducting and reporting Phase 3 studies across obesity and related conditions. Trial status should be checked against the live trial registry because recruitment and completion dates can change.
Questions to ask when reading a study
- Who was included and excluded?
- What was the comparator?
- What was the primary endpoint?
- How long did the study run?
- Were results reported for all participants?
- What limitations did the researchers identify?